VanEck Pharmaceutical ETF (PPH)

NASDAQ: PPH · IEX Real-Time Price · USD
90.70
-0.19 (-0.21%)
Mar 28, 2024, 4:00 PM EDT - Market closed
-0.21%
Assets $529.36M
Expense Ratio 0.36%
PE Ratio 21.99
Shares Out 5.89M
Dividend (ttm) $1.70
Dividend Yield 1.88%
Ex-Dividend Date Dec 27, 2023
Payout Ratio 41.14%
1-Year Return +18.83%
Volume 88,044
Open 90.94
Previous Close 90.89
Day's Range 90.68 - 91.16
52-Week Low 74.05
52-Week High 91.14
Beta 0.48
Holdings 27
Inception Date Feb 1, 2000

About PPH

Fund Home Page

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is issued by VanEck.

Asset Class Equity
Category Health
Region North America
Stock Exchange NASDAQ
Ticker Symbol PPH
ETF Provider VanEck
Index Tracked MVIS US Listed Pharmaceutical 25

Top 10 Holdings

63.54% of assets
Name Symbol Weight
Eli Lilly and Company LLY 11.73%
Novo Nordisk A/S NVO 9.37%
Johnson & Johnson JNJ 6.64%
Merck & Co., Inc. MRK 6.20%
AbbVie Inc. ABBV 5.99%
AstraZeneca PLC AZN 5.16%
Novartis AG NVS 4.65%
Cencora COR 4.63%
Sanofi SNY 4.61%
McKesson Corporation MCK 4.56%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Dec 27, 2023 $0.3074 Dec 29, 2023
Oct 2, 2023 $0.3398 Oct 6, 2023
Jul 3, 2023 $0.3891 Jul 7, 2023
Apr 3, 2023 $0.6641 Apr 10, 2023
Dec 28, 2022 $0.240 Dec 30, 2022
Oct 3, 2022 $0.2696 Oct 7, 2022
Full Dividend History

News

Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.

Despite Eli Lilly's monster 66.8% gain on the year because of weight-loss drugs, the S&P 500 Pharmaceuticals index is down 2.3%.

Other symbols: BMYJNJLLYPFE
4 months ago - Barrons

Biotech Stocks Are Rallying, but the Outlook Isn't Good

The XBI has been climbing this month. On Tuesday it jumped 5.4% to close at $70.91.

Other symbols: XBIXLV
4 months ago - Barrons

Write A Prescription For This Pharma ETF

After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccin...

3 years ago - Benzinga

A Divergence Has Occurred In Healthcare

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech.

Other symbols: BBH
3 years ago - Benzinga

3 ETFs in Focus as Race for Vaccine Intensifies

Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.

Other symbols: PTHXBI
4 years ago - Investopedia

Best Performing Pharmaceutical ETFs for Q3 2020

The best pharmaceutical ETFs for Q3 2020 are KURE, XPH, and PPH.

Other symbols: KUREXPH
4 years ago - Investopedia